Impacts of neoadjuvant chemoradiotherapy on the immune landscape of esophageal squamous cell carcinomaResearch in context

Summary: Background: Neoadjuvant chemoradiotherapy (neoCRT) followed by surgery is the most common approach for locally advanced resectable esophageal squamous cell carcinoma (ESCC) patients. How neoCRT impacts ESCC tumor immune microenvironment (TIME) has not been fully understood. Methods: Single...

Full description

Bibliographic Details
Main Authors: Jing Wen, Shuogui Fang, Yi Hu, Mian Xi, Zelin Weng, Chuqing Pan, Kongjia Luo, Yihong Ling, Renchun Lai, Xiuying Xie, Xiaodan Lin, Ting Lin, Jiyang Chen, Qianwen Liu, Jianhua Fu, Hong Yang
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:EBioMedicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396422005539